Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OASIS: Suzetrigine for Post-Operative Pain in Facial Plastic Surgery
NCT07257133Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Oct 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of suzetrigine in postoperative pain, sponsored by Mayo Clinic. Started Oct 2025; status: completed.
02
Drugs
suzetrigine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07257133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07257133.